The growing interest in potent weight management has led to considerable research into novel treatments. Recently , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated promising results in clinical trials, indicating potential for substantial weight loss . Consequently , numerous individ